Odonate Therapeutics
Pharmaceuticals, 335 S 560 W, San Diego, California, 84042, United States, 51-200 Employees
Phone Number: 85********
Who is ODONATE THERAPEUTICS
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s init...
Read More
-
Headquarters: 335 S 560 W, San Diego, California, 84042, United States
-
Date Founded: 2013
-
Employees: 51-200
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ODONATE THERAPEUTICS
Odonate Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Odonate Therapeutics
Answer: Odonate Therapeutics's headquarters are located at 335 S 560 W, San Diego, California, 84042, United States
Answer: Odonate Therapeutics's phone number is 85********
Answer: Odonate Therapeutics's official website is https://odonate.com
Answer: Odonate Therapeutics's revenue is $250 Million to $500 Million
Answer: Odonate Therapeutics's SIC: 2834
Answer: Odonate Therapeutics's NAICS: 325412
Answer: Odonate Therapeutics has 51-200 employees
Answer: Odonate Therapeutics is in Pharmaceuticals
Answer: Odonate Therapeutics contact info: Phone number: 85******** Website: https://odonate.com
Answer: Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent belonging to a class of drugs known as taxanes, which are widely used in the treatment of cancer. In December 2017, Odonate initiated CONTESSA, a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with locally advanced or metastatic breast cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month